Rubedo Life Sciences and SVAX Forge Strategic Partnership at FII Week in Riyadh
Rubedo Life Sciences, Inc., an AI-powered, clinical-stage biotech firm specializing in selective cellular rejuvenation therapies, has unveiled a strategic partnership with SVAX at the Future Investment Initiative (FII) week in Riyadh. This collaboration aims to accelerate the development of RLS-1946, Rubedo’s leading candidate, as it progresses through Phase 2 clinical
